Page last updated: 2024-11-05

talactoferrin alfa and Colonic Neoplasms

talactoferrin alfa has been researched along with Colonic Neoplasms in 1 studies

talactoferrin alfa: recombinant human lactoferrin, an oral drug for treatment of refractory solid tumors; in Phase I trial 5/2006

Colonic Neoplasms: Tumors or cancer of the COLON.

Research Excerpts

ExcerptRelevanceReference
" Talactoferrin alfa (TLf) is a recombinant human Lf shown to protect against sepsis and necrotizing enterocolitis as well as cancer."3.80Comparison of bioactivities of talactoferrin and lactoferrins from human and bovine milk. ( Du, X; Jiang, R; Lönnerdal, B, 2014)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jiang, R1
Du, X1
Lönnerdal, B1

Other Studies

1 other study available for talactoferrin alfa and Colonic Neoplasms

ArticleYear
Comparison of bioactivities of talactoferrin and lactoferrins from human and bovine milk.
    Journal of pediatric gastroenterology and nutrition, 2014, Volume: 59, Issue:5

    Topics: Animals; Apoptosis; Caco-2 Cells; Cattle; Cell Proliferation; Chemokine CCL20; Colonic Neoplasms; En

2014